相关实验视频
Updated: May 9, 2025

12:00
A Simplified Technique for Producing an Ischemic Wound Model
Published on: May 2, 2012
17.2K
糖尿病足的微环境:对治疗和治疗策略的影响
Jixue Wang1, Xirui Yang2, Tao Zhou1
1Department of Peripheral Vascular Medicine, First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan Province, China.
概括
糖尿病足 (DFU) 是由当地的微环境影响的慢性伤口. 了解缺氧,炎症和细胞作用是开发新疗法以改善DFU愈合的关键.
科学领域:
- 生物医学工程 生物医学工程
- 伤口治愈研究研究 伤口治愈研究
- 糖尿病学 糖尿病学
背景情况:
- 糖尿病足 (DFU) 是普遍存在的,不愈合的伤口显著影响糖尿病患者的生活质量.
- 在DFU中,治愈非常依赖于当地的微环境,包括氧气水平,炎症和细胞活动.
- 血液循环受损导致缺氧,阻碍细胞功能,延迟伤口修复.
研究的目的:
- 为了阐明糖尿病足微环境的复杂动态.
- 确定影响糖尿病慢性伤口愈合的关键因素.
- 为DFU制定有针对性的治疗策略提供信息.
主要方法:
- 对DFU病理生理学现有文献的审查.
- 分析伤口愈合中的细胞和分子机制.
- 探索微环境因素,如缺氧和炎症.
主要成果:
- 缺氧会损害细胞功能和营养供应,延迟DFU的愈合.
- 慢性炎症的特征是过度的促炎细胞因子,加剧组织损伤.
- 纤维细胞,角质细胞和巨细胞是参与DFU修复不同阶段的关键细胞类型.
结论:
- 对DFU微环境的彻底理解对于推进治疗至关重要.
- 针对缺氧,炎症和细胞功能障碍可以促进伤口愈合.
- 开发先进的药物输送系统和生物活性材料对DFU管理具有前景.
相关概念视频
The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
Clinical Applications of Epidermal Stem Cells
2.6K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.6K
Diabetes: Management and Pharmacotherapy
204
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
204

